References
1. Mody RJ, Wu YM, Lonigro RJ, Cao XH, Roychowdhury S, Vats P, et al.
Integrative Clinical Sequencing in the Management of Refractory or
Relapsed Cancer in Youth. Jama-Journal of the American Medical
Association. 2015;314(9):913-25.
2. Tsimberidou AM, Wen S, Hong DS, Wheler JJ, Falchook GS, Fu S, et al.
Personalized medicine for patients with advanced cancer in the phase I
program at MD Anderson: validation and landmark analyses. Clin Cancer
Res. 2014;20(18):4827-36.
3. Schwaederle M, Parker BA, Schwab RB, Daniels GA, Piccioni DE, Kesari
S, et al. Precision Oncology: The UC San Diego Moores Cancer Center
PREDICT Experience. Molecular Cancer Therapeutics. 2016;15(4):743-52.
4. O’Bryant CL, Wenger SD, Kim M, Thompson LA. Crizotinib: a new
treatment option for ALK-positive non-small cell lung cancer. Ann
Pharmacother. 2013;47(2):189-97.
5. Paez JG, Jänne PA, Lee JC, Tracy S, Greulich H, Gabriel S, et al.
EGFR mutations in lung cancer: correlation with clinical response to
gefitinib therapy. Science. 2004;304(5676):1497-500.
6. Abbou SD, Shulman DS, DuBois SG, Crompton BD. Assessment of
circulating tumor DNA in pediatric solid tumors: The promise of liquid
biopsies. Pediatr Blood Cancer. 2019;66(5):e27595.
7. Ikeda S, Tsigelny IF, Skjevik Å, Kono Y, Mendler M, Kuo A, et al.
Next-Generation Sequencing of Circulating Tumor DNA Reveals Frequent
Alterations in Advanced Hepatocellular Carcinoma. Oncologist.
2018;23(5):586-93.
8. Schwaederle M, Parker BA, Schwab RB, Fanta PT, Boles SG, Daniels GA,
et al. Molecular tumor board: the University of California-San Diego
Moores Cancer Center experience. The oncologist. 2014;19(6):631-6.
9. Pincez T, Clément N, Lapouble E, Pierron G, Kamal M, Bieche I, et al.
Feasibility and clinical integration of molecular profiling for target
identification in pediatric solid tumors. Pediatr Blood Cancer.
2017;64(6).
10. Takagi M, Yoshida M, Nemoto Y, Tamaichi H, Tsuchida R, Seki M, et
al. Loss of DNA Damage Response in Neuroblastoma and Utility of a PARP
Inhibitor. J Natl Cancer Inst. 2017;109(11).